MedTrace Logo

The Use of Non-ICG-Enhanced Lymphatic Vessels for LVA

NCT06742242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2024-12-19

No results posted yet for this study

Summary

The aim of the present study was to investigate the impact of non-ICG(+) LVs on the outcomes after LVA compared to ICG(+) LVs with propensity-score-match analysis.

Conditions

  • Lymphedema

Interventions

PROCEDURE

lymphaticovenous anastomosis

supermicrosurgical lymphatic vessel to recipient ven lumen-to-lumen coaptation

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06742242 on ClinicalTrials.gov